[Progress in the field of drug developments. 13].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000928:Antidepressive Agents / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D000978:Antiparkinson Agents / Q000494:pharmacology; D014150:Antipsychotic Agents / Q000494:pharmacology; D000998:Antiviral Agents / Q000494:pharmacology; D001067:Appetite Depressants / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D006633:Histamine Antagonists / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology; D006801:Humans; D010525:Peripheral Nerves / Q000187:drug effects; D010600:Pharmacology; D012702:Serotonin Antagonists / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000935:Antifungal Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D000998:Antiviral Agents; D001067:Appetite Depressants; D000697:Central Nervous System Stimulants; D006633:Histamine Antagonists; D006728:Hormones; D012702:Serotonin Antagonists; D014149:Tranquilizing Agents
Fortschritte auf dem gebiet der arzneimittelentwicklung. teil 13.